Colorectal cancer incidence has paralleled increases in human development across most countries. Yet, marked decreases in incidence are now observed in countries that have attained very high human development. Thus, in this study, we explored the relationship between human development and colorectal cancer incidence, and in particular assessed whether national transitions to very high human development are linked to temporal patterns in colorectal cancer incidence. For these analyses, we utilized the Human Development Index (HDI) and annual incidence data from regional and national cancer registries. Truncated (30-74 years) age-standardized incidence rates were calculated. Yearly incidence rate ratios and HDI ratios, before and after transitioning to very high human development, were also estimated. Among the 29 countries investigated, colorectal cancer incidence was observed to decrease after reaching the very high human development threshold for 12 countries; decreases were also observed in a further five countries, but the age-standardized incidence rates remained higher than that observed at the threshold. Such declines or stabilizations are likely due to colorectal cancer screening in some populations, as well as varying levels of exposure to protective factors. In summary, it appears that there is a threshold at which human development predicts a stabilization or decline in colorectal cancer incidence, though this pattern was not observed for all countries assessed. Future cancer planning must consider the increasing colorectal cancer burden expected in countries transitioning towards higher levels of human development, as well as possible declines in incidence among countries reaching the highest development level.
With increasing social mobility and economic growth, countries increasingly adapt to lifestyles and behaviors that are commonly associated with westernization. As a result, transitions in human development are associated with increases in cancer rates overall and for certain types. 1 In particular, colorectal cancer has been considered one of the clearest markers of transition, 2 as increases in colorectal cancer incidence have generally paralleled increases in human development across most countries. [1] [2] [3] Yet, colorectal cancer incidence rates have stabilized or declined recently in many countries that have attained very high levels of human development, such as the United States, Japan and Australia. 2, 3 Thus, in this explorative study, we sought to better understand the global relationship between human development and colorectal cancer incidence, and in particular assess whether attaining very high human development is a predictive marker of a deceleration and subsequent decline in colorectal cancer rates.
Material and Methods

Data sources
In order to assess societal and economic development, we used the Human Development Index (HDI). The HDI is a composite measure of life expectancy, educational attainment and gross national income estimated by the United Nations Development Programme (UNDP). 4 Temporal HDI data 4 was linearly interpolated and extrapolated to obtain HDI values for years within the range of 1980-2011 where values were unavailable. These annual, country-specific HDI values were then linked to corresponding high quality colorectal cancer incidence data from regional or national cancer registries with at least five years of consecutive annual data using Cancer Incidence in Five Continents (CI5) plus 5 and publically available data from European countries, 6, 7 Australia, 8 New Zealand 9 and the United States. 10 As we sought to investigate the impact of attaining very high HDI on colorectal cancer incidence, only countries that reached the threshold of very high HDI (defined using the UNDP proposed cut-off of 0.80 4 ) during the study period of 1980-2011 were included in this study. Using this inclusion criterion, 29 countries were included from the following regions: Europe (n 5 21), North America (n 5 2), Asia (n 5 4) and Oceania (n 5 2); detailed information of each cancer registry can be found in the Acknowledgements section.
Statistical analyses
Truncated (30-74 years) age-standardized incidence rates (ASR) per 100,000 were calculated using the world standard population.
11 Country-specific trends of colorectal cancer incidence in relation to the HDI were then estimated by calculating yearly HDI ratios and incidence rate ratios (IRRs).
To calculate the HDI ratio, the HDI value of the year of interest was divided by the HDI value for the reference year, which was the year in which the country transitioned to the very high HDI threshold. The IRR was calculated by dividing the ASR for the year of interest by the ASR for the reference year using age-period-cohort models, 12 which take into account the time-varying independent effects of age, period and birth cohort on colorectal cancer incidence. All analyses and figures were created using Stata 13.1 statistical software. 13 
Results
In Tables 1 and 2 we present the HDI ratios and IRRs across the calendar years assessed for each country. For all countries, the HDI increased over time (Table 1) . However, when the IRRs were assessed, three different groups of countries were identified considering the temporal patterns observed for colorectal cancer incidence: one including countries with decreasing colorectal cancer incidence after the HDI threshold, with IRRs now lower than at the HDI threshold (Group 1, n 5 12 countries), one including countries with decreasing colorectal cancer incidence after the HDI threshold, but with IRRs higher than that observed at the HDI threshold (Group 2, n 5 5 countries), and one including countries with continuously increasing colorectal cancer incidence after the HDI threshold (Group 3, n 5 12 countries; Table 2 ). All results are therefore presented according to these three groups.
Group 1
After attaining very high human development, colorectal cancer incidence decreased for the following countries: Austria, Canada, Czech Republic, Estonia, France, Germany, Ireland, Israel, Lithuania, New Zealand, Singapore and the United States ( Figure 1a) . Notably, both North American countries included in this study, as well as four out of the five Western European countries included, were categorized into this group. For Canada, France, Estonia, Ireland, Singapore and the United States the decline occurred within a year of attaining very high human development, whilst other countries experienced slight increases in the IRRs before they subsequently declined. The most marked declines in colorectal cancer incidence were observed for the United States and New Zealand, where IRRs of 0.70 and 0.81 were observed in 2010, respectively (Table 2) ; however, it is worth noting that these countries were among the earliest to reach the HDI threshold and thus had more study years after the HDI threshold to observe decreases compared to other countries. Finally, although Canada and Ireland both experienced declines after initially passing the very high HDI threshold, increases in colorectal cancer incidence were observed more recently for both countries.
What's new?
Lifestyles associated with westernization are increasingly predominant in countries where social mobility and economic growth are on the rise. The incidence of colorectal cancer (CRC) has likewise risen in those countries, though some areas with very high human development are now experiencing alternate trends. Here, CRC incidence was found to have decreased for 12 out of 29 countries that have attained very high levels of human development. Though not evident for all countries analyzed, the data suggest the existence of a threshold at which CRC incidence stabilizes or declines according to the Human Development Index. The reference (threshold) year is the first year in which the country reached the threshold of very high human development (HDI 0.8). HDI ratios highlighted in red symbolize an increasing HDI ratio relative to the previous year.
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Fidler et al. The reference (threshold) year is the first year in which the country reached the threshold of very high human development (Human Development Index (HDI) 0.8). IRRs highlighted in green symbolize a declining IRR relative to the previous year. IRRs highlighted in red symbolize an increasing IRR relative to the previous year.
Group 2
Declines in colorectal cancer incidence were also observed among the countries included in this group, but the ASRs remained higher than that observed during the reference year (Fig. 1b) . In particular, after surpassing the very high HDI threshold, the IRRs for Finland and Switzerland increased gradually, peaking at HDI values of 0.87 (2007, IRR 5 1.13) and 0.90 (2002, IRR 5 1.09), respectively, and then subsequently declining ( Table 2 ). The IRR for Australia similarly peaked at 1.13 when the HDI value was 0.89, but the decline in colorectal cancer incidence after this point was more substantial than that observed for Finland and Switzerland, with the IRR in the final year being 1.06. The largest increases in the ASRs after the HDI threshold were observed for Iceland and Japan, which peaked at IRRs of 1.32 and 1.20, respectively; although both countries saw more substantial declines in colorectal cancer incidence than that observed for Finland or Switzerland, the IRRs for Iceland remained higher at the last year compared to both countries, and Japan's IRR at the last year was comparable to Finland's IRR.
Group 3
Colorectal cancer incidence was observed to increase for all countries included in this group after the very high HDI threshold was reached (Fig. 1c) . Notably, with the exception of the Czech Republic, all Eastern European and Southern European countries included in this study were classified into this group. This group also contained several Northern European countries and the Netherlands, the latter of which was the only Western European country to not experience declines in colorectal cancer incidence. Based upon the figure, we can visually see three clusters of countries: those with a more rapid increase in the ASRs after the HDI threshold (Italy, the Republic of Korea, Slovenia, Spain and the Netherlands), those with a more gradual increase in the ASRs after the HDI threshold (Denmark, Norway, Sweden and the United Kingdom), and those recently reaching the HDI threshold with minimal increases thereafter (Malta, Poland and Slovakia). For the first cluster, the ASR increases rapidly after the HDI threshold (Table 2 ) despite minimal increases in the HDI (Table 1) . For example, the ASR in the Republic of Korea increased by 63% from 1999 to 2007, whilst the HDI only increased by 7% for the same period. This pattern is in contrast to the second cluster, which observed more gradual increases in colorectal cancer incidence that appeared to parallel increases in the HDI. Although the IRRs in the second cluster were generally lower compared to the first, the IRR at the last observation year for Norway (IRR 5 1.27) was comparable to the corresponding IRRs observed in Italy (IRR 5 1.21), Spain (IRR 5 1.27) and The Netherlands (IRR 5 1.28). Finally, the last group includes the countries that most recently transitioned to the very high human development level, and thus there is limited data available for assessing trends after the HDI threshold. Although Malta has observed more substantial increases in colorectal cancer incidence in the initial years after the threshold, with the IRR of the last year being 1.06, the corresponding IRR for Poland and Slovakia remain low at 1.01 and thus it is less clear if the colorectal cancer incidence in these countries will continue to increase, or will potentially decline in the future.
Discussion
In summary, there appears to be a threshold at which the HDI predicts a stabilization or decline in colorectal cancer incidence. For some countries this threshold was reached once the country transitioned to very high human development, whilst others were found to have stabilizing or decreasing incidence rates at higher HDI values. Although colorectal Figure 1 . Country-specific incidence rate ratios (IRRs) and Human Development Index (HDI) ratios, before and after the reference (threshold) year, by colorectal cancer pattern group. The reference year is the first year in which the country reached the threshold of very high human development (HDI 0.8). (a) illustrates the relative trends for Group 1 countries, where the incidence declined after the threshold and the ASRs after the threshold were lower than at the threshold. (b) illustrates the relative trends for Group 2 countries, where the incidence declined after the threshold, but the ASRs after the threshold were higher than at the threshold. 
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cancer incidence decreased for the majority of countries assessed in this study, decreases were not observed for all countries, particularly those in Southern and Eastern Europe. Thus, it is important when predicting the future colorectal cancer burden in countries with very high human development that both possible trajectories are considered.
One of the possible explanations for the colorectal cancer patterns observed is screening, for which national indicators vary widely in terms of starting year of screening, test utilized and coverage (Supporting Information eTable 1l) . Principally, colorectal cancer screening was implemented earlier in many of the countries with decreasing incidence, 14 with the earliest organized programs started in Israel in 1990, Japan in 1992 and the Czech Republic in 2000. The greatest colorectal cancer incidence decrease was observed in the United States, however, where the early introduction of opportunistic screening in the 1970-1980s, national support from professional and cancer societies, high public awareness and coverage and increasing usage of colonoscopy have contributed to the decline. 15 Observed declines in colorectal cancer incidence in the United States and abroad might be the longterm effect of screening through the removal of precancerous polyps. 16 Conversely, colorectal cancer screening has generally commenced later for Group 3 countries, with Italy, Malta, Norway, Poland, Spain and The Netherlands still piloting or rolling-out national programs 14 ; screening can increase colorectal cancer incidence in the short-term through the increased detection of prevalent cases, 17 which may partially explain the rise in incidence after screening.
The type of test utilized in the screening program may also be related to the colorectal cancer trends observed. Countries utilizing fecal immunochemical tests, flexible sigmoidoscopies or colonoscopies may be more likely to benefit from decreases in colorectal cancer incidence compared to countries utilizing the guaiac fecal occult blood test, as the latter is limited by moderate sensitivity for advanced adenomas and cancer 18 and has not been shown to decrease colorectal cancer incidence when utilized in annual or biennial screening.
14 When the type of test utilized in each country was assessed, however, we did not observe a noticeable relationship between the type of test and the three groups identified in this study (Supporting Information eTable 1), and thus the relative importance of this factor in the different colorectal cancer patterns observed is unclear.
The colorectal cancer incidence trends observed cannot be solely attributed to screening though, as the magnitude of the changes observed, coupled with declining or stabilizing rates among young generations (i.e., those not receiving screening) in some countries, suggest that other factors must be involved. 19 Other possible explanations related to the decrease in colorectal cancer incidence include a change in diet, where the reduced consumption of smoked and cured meats may result in a lower exposure to carcinogenic nitrosamines, and changes in the gastrointestinal microbiome. 19 Furthermore, protective factors are likely to have contributed to the stabilization or decline of colorectal cancer incidence; these include the use of dietary supplements (e.g., calcium), 20 hormone-replacement therapy, 21, 22 statins 19 and antiinflammatory drugs (e.g., aspirin), [23] [24] [25] [26] the last of which may have chemopreventative effects. Contrarily, adverse riskfactors related to westernization, such as obesity, physical inactivity, alcohol consumption and poor diet, have all been linked to colorectal cancer. [27] [28] [29] Such factors have changed dramatically in their prevalence and distribution since the 1950s, and likely contribute to the increasing colorectal cancer rates in some of the countries assessed.
In summary, the evaluation of colorectal cancer on a global scale is complex, even if restricted to very high HDI countries, as each country differs in their early detection practices and pattern of risk factors. As the purpose of this study was to descriptively explore the relationship between human development and stabilizing or declining colorectal cancer incidence, our study is unable to separate the relative importance of screening, protective factors, and risk factors in the patterns observed. Nonetheless, these results highlight a potential threshold at which the HDI predicts colorectal cancer incidence, which should serve as a catalyst for future research seeking to better understand the interplay between global colorectal cancer patterns, human development and the impact of these active operators. In particular, further research that projects the future colorectal cancer burden by the HDI can serve as a complementary analysis to standard cancer projections, and may potentially share new insights into the relationship between colorectal cancer incidence and human development. These findings may also act as an alert for planning needs globally, given an increasing colorectal cancer burden is predicted in countries of low to high human development, representing 80% of the global population, 1 as they transition towards higher levels of human development.
